Secretome Therapeutics Alternatives & Competitors
12 companies similar to Secretome Therapeutics — Revolutionizing cell therapy for inflammatory diseases via neonatal cardiac prog...
Companies similar to Secretome Therapeutics
Stemedica Cell Technologies, Inc
Developing Breakthrough Progenitor Cell and Protein Therapeutics
Promethera Biosciences
Innovative biopharmaceuticals harnessing healthy human liver cells to treat liver diseases...
Tr1X
Engineering cures for patients with autoimmune & inflammatory diseases.
Third Harmonic Bio
Advancing the next wave of medicine for inflammatory diseases
Rival Readout
Competing with Secretome Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Immusoft
Cell therapy company dedicated to improving the lives of patients with rare diseases
Artax Biopharma Inc
Developing oral first-in-class Nck blockers for the treatment of T cell mediated autoimmun...
ZaBeCor Pharmaceuticals
Pioneering molecular advancements for asthma, allergies, and a spectrum of inflammatory an...
American Gene Technologies® International Inc.
Our mission is to leverage the power of gene and cell therapy to reduce human suffering fr...
Promedior
Pioneering advanced therapies to heal fibrotic and inflammatory diseases at their source,...
Ixaka
An integrated cell and gene therapy company focused on the natural power of the body to cu...
Cell Vault
The world's first t-cell bank. Cryo-preserving healthy cells today, to fight the diseases...
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Secretome Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. The 11 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.